Surprisingly small effect of antiviral treatment in patients with hepatitis C

Annals of Internal Medicine

Volumn 136, Issue 4, 2002, Pages 288-292

  Falck Ytter, Yngve ^a   Kale, Hemangi ^a   Mullen, Kevin D ^a   Sarbah, Steedman A ^a   Sorescu, Lucian ^a   McCullough, Arthur J ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; RIBAVIRIN;

ADULT; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SOCIAL STATUS; UNITED STATES; VIRUS LOAD;

EID: 0037133079     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-136-4-200202190-00008     Document Type: Article

References (20)

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
2. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
3. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C
4. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
5. Randomized trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
6. Peginterferon alfa-2a in patients with chronic hepatitis C
7. The alcoholic patient with hepatitis C virus infection
8. Depression among needle exchange program and methadone maintenance dients
9. Hepatitis C therapy in treatment-naïve patients
10. Clinical toxicity of the inrerferons
11. Recruiting minorities inro clinical trials: Toward a participant-friendly system
12. Statement: Management of hepatitis C
13. Reluctance of urban clinic patients to undergo treatment with interferon-alpha
14. How often are referred chronic hepatitis C patients candidates for anti-viral therapy?
15. Hepatitis C virus infection
16. Hepatitis C and the correctional population
17. Future options for the management of hepatitis C
18. Brief intervention for female heavy drinkers in routine general practice: A 3-year randomized, controlled study
19. Natural history of liver fibrosis progression in patients with chronic hepatitis C
20. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis